Literature DB >> 27760051

Long noncoding RNA Tug1 regulates mitochondrial bioenergetics in diabetic nephropathy.

Jianyin Long, Shawn S Badal, Zengchun Ye, Yin Wang, Bernard A Ayanga, Daniel L Galvan, Nathanael H Green, Benny H Chang, Paul A Overbeek, Farhad R Danesh.   

Abstract

The regulatory roles of long noncoding RNAs (lncRNAs) in transcriptional coactivators are still largely unknown. Here, we have shown that the peroxisome proliferator-activated receptor γ (PPARγ) coactivator α (PGC-1α, encoded by Ppargc1a) is functionally regulated by the lncRNA taurine-upregulated gene 1 (Tug1). Further, we have described a role for Tug1 in the regulation of mitochondrial function in podocytes. Using a murine model of diabetic nephropathy (DN), we performed an unbiased RNA-sequencing (RNA-seq) analysis of kidney glomeruli and identified Tug1 as a differentially expressed lncRNA in the diabetic milieu. Podocyte-specific overexpression (OE) of Tug1 in diabetic mice improved the biochemical and histological features associated with DN. Unexpectedly, we found that Tug1 OE rescued the expression of PGC-1α and its transcriptional targets. Tug1 OE was also associated with improvements in mitochondrial bioenergetics in the podocytes of diabetic mice. Mechanistically, we found that the interaction between Tug1 and PGC-1α promotes the binding of PGC-1α to its own promoter. We identified a Tug1-binding element (TBE) upstream of the Ppargc1a gene and showed that Tug1 binds with the TBE to enhance Ppargc1a promoter activity. These findings indicate that a direct interaction between PGC-1α and Tug1 modulates mitochondrial bioenergetics in podocytes in the diabetic milieu.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27760051      PMCID: PMC5096930          DOI: 10.1172/JCI87927

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  67 in total

1.  Activation of peroxisome proliferator-activated receptor-γ coactivator 1α ameliorates mitochondrial dysfunction and protects podocytes from aldosterone-induced injury.

Authors:  Yanggang Yuan; Songming Huang; Wenyan Wang; Yingying Wang; Ping Zhang; Chunhua Zhu; Guixia Ding; Bicheng Liu; Tianxin Yang; Aihua Zhang
Journal:  Kidney Int       Date:  2012-05-30       Impact factor: 10.612

2.  PPM1A functions as a Smad phosphatase to terminate TGFbeta signaling.

Authors:  Xia Lin; Xueyan Duan; Yao-Yun Liang; Ying Su; Katharine H Wrighton; Jianyin Long; Min Hu; Candi M Davis; Jinrong Wang; F Charles Brunicardi; Yigong Shi; Ye-Guang Chen; Anming Meng; Xin-Hua Feng
Journal:  Cell       Date:  2006-06-02       Impact factor: 41.582

Review 3.  Metabolic control through the PGC-1 family of transcription coactivators.

Authors:  Jiandie Lin; Christoph Handschin; Bruce M Spiegelman
Journal:  Cell Metab       Date:  2005-06       Impact factor: 27.287

4.  PGC-1α promotes recovery after acute kidney injury during systemic inflammation in mice.

Authors:  Mei Tran; Denise Tam; Amit Bardia; Manoj Bhasin; Glenn C Rowe; Ajay Kher; Zsuzsanna K Zsengeller; M Reza Akhavan-Sharif; Eliyahu V Khankin; Magali Saintgeniez; Sascha David; Deborah Burstein; S Ananth Karumanchi; Isaac E Stillman; Zoltan Arany; Samir M Parikh
Journal:  J Clin Invest       Date:  2011-09-01       Impact factor: 14.808

5.  Mitochondrial biogenesis in kidney disease.

Authors:  Joel M Weinberg
Journal:  J Am Soc Nephrol       Date:  2011-02-25       Impact factor: 10.121

6.  Mitochondrial fission triggered by hyperglycemia is mediated by ROCK1 activation in podocytes and endothelial cells.

Authors:  Wenjian Wang; Yin Wang; Jianyin Long; Jinrong Wang; Sandra B Haudek; Paul Overbeek; Benny H J Chang; Paul T Schumacker; Farhad R Danesh
Journal:  Cell Metab       Date:  2012-02-08       Impact factor: 27.287

7.  A PGC-1α isoform induced by resistance training regulates skeletal muscle hypertrophy.

Authors:  Jorge L Ruas; James P White; Rajesh R Rao; Sandra Kleiner; Kevin T Brannan; Brooke C Harrison; Nicholas P Greene; Jun Wu; Jennifer L Estall; Brian A Irving; Ian R Lanza; Kyle A Rasbach; Mitsuharu Okutsu; K Sreekumaran Nair; Zhen Yan; Leslie A Leinwand; Bruce M Spiegelman
Journal:  Cell       Date:  2012-12-07       Impact factor: 41.582

Review 8.  Mechanisms of Long Non-coding RNAs in Mammalian Nervous System Development, Plasticity, Disease, and Evolution.

Authors:  James A Briggs; Ernst J Wolvetang; John S Mattick; John L Rinn; Guy Barry
Journal:  Neuron       Date:  2015-12-02       Impact factor: 17.173

9.  Abnormal glucose homeostasis in skeletal muscle-specific PGC-1alpha knockout mice reveals skeletal muscle-pancreatic beta cell crosstalk.

Authors:  Christoph Handschin; Cheol Soo Choi; Sherry Chin; Sheene Kim; Dan Kawamori; Amarnath J Kurpad; Nicole Neubauer; Jiang Hu; Vamsi K Mootha; Young-Bum Kim; Rohit N Kulkarni; Gerald I Shulman; Bruce M Spiegelman
Journal:  J Clin Invest       Date:  2007-11       Impact factor: 14.808

10.  Protective role of PGC-1α in diabetic nephropathy is associated with the inhibition of ROS through mitochondrial dynamic remodeling.

Authors:  Kaifeng Guo; Junxi Lu; Yan Huang; Mian Wu; Lei Zhang; Haoyong Yu; Mingliang Zhang; Yuqian Bao; John Cijiang He; Haibing Chen; Weiping Jia
Journal:  PLoS One       Date:  2015-04-08       Impact factor: 3.240

View more
  145 in total

1.  Long non-coding RNA TUG1 and its molecular mechanisms in polycystic ovary syndrome.

Authors:  Ying Li; Jun Zhang; Yu-Dong Liu; Xing-Yu Zhou; Xin Chen; Jing Zhe; Qing-Yan Zhang; Xiao-Fei Zhang; Ying-Xue Chen; Zhe Wang; Shi-Ling Chen
Journal:  RNA Biol       Date:  2020-07-02       Impact factor: 4.652

2.  Urinary expression of long non-coding RNA TUG1 in non-diabetic patients with glomerulonephritides.

Authors:  Fernando Javier Salazar-Torres; Miguel Medina-Perez; Zesergio Melo; Claudia Mendoza-Cerpa; Raquel Echavarria
Journal:  Biomed Rep       Date:  2020-11-20

Review 3.  Long noncoding RNAs in the metabolic control of inflammation and immune disorders.

Authors:  Junfang Xu; Xuetao Cao
Journal:  Cell Mol Immunol       Date:  2018-05-23       Impact factor: 11.530

Review 4.  Epigenetics and epigenomics in diabetic kidney disease and metabolic memory.

Authors:  Mitsuo Kato; Rama Natarajan
Journal:  Nat Rev Nephrol       Date:  2019-06       Impact factor: 28.314

Review 5.  The role of epigenetics in renal ageing.

Authors:  Paul G Shiels; Dagmara McGuinness; Maria Eriksson; Jeroen P Kooman; Peter Stenvinkel
Journal:  Nat Rev Nephrol       Date:  2017-06-19       Impact factor: 28.314

Review 6.  PPARγ-Coactivator-1α, Nicotinamide Adenine Dinucleotide and Renal Stress Resistance.

Authors:  Ali Poyan Mehr; Samir M Parikh
Journal:  Nephron       Date:  2017-06-08       Impact factor: 2.847

7.  Chronic kidney disease attenuates the plasma metabolome response to insulin.

Authors:  Baback Roshanravan; Leila R Zelnick; Daniel Djucovic; Haiwei Gu; Jessica A Alvarez; Thomas R Ziegler; Jorge L Gamboa; Kristina Utzschneider; Bryan Kestenbaum; Jonathan Himmelfarb; Steven E Kahn; Daniel Raftery; Ian H de Boer
Journal:  JCI Insight       Date:  2018-08-23

8.  Real-time in vivo mitochondrial redox assessment confirms enhanced mitochondrial reactive oxygen species in diabetic nephropathy.

Authors:  Daniel L Galvan; Shawn S Badal; Jianyin Long; Benny H Chang; Paul T Schumacker; Paul A Overbeek; Farhad R Danesh
Journal:  Kidney Int       Date:  2017-07-26       Impact factor: 10.612

9.  Increasing the level of peroxisome proliferator-activated receptor γ coactivator-1α in podocytes results in collapsing glomerulopathy.

Authors:  Szu-Yuan Li; Jihwan Park; Chengxiang Qiu; Seung Hyeok Han; Matthew B Palmer; Zoltan Arany; Katalin Susztak
Journal:  JCI Insight       Date:  2017-07-20

Review 10.  Linking diabetic vascular complications with LncRNAs.

Authors:  Amy Leung; Vishnu Amaram; Rama Natarajan
Journal:  Vascul Pharmacol       Date:  2018-02-03       Impact factor: 5.773

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.